Moreover, the upregulation of thioredoxin (Trx) has been experimentally shown to impede the advancement of insulin resistance in vivo, encompassing both type 1 and type 2 diabetes, as reported by Yamamoto et al.165. The gene discussed is TXN; the disease is Insulin resistance.